Evidence map›Paper›PMID 41604596›Full record

ArticleDiabetes care2026

Global, Regional, and National Estimates of Undiagnosed Diabetes in Adults: Findings From the 2025 IDF Diabetes Atlas.

Felix Teufel, Katherine Orgutsova, Irini Genitsaridi, Rodrigo M Carrillo-Larco, Jithin Sam Varghese, Maja E Marcus, Julian W Sacre, Seyedeh Forough Sajjadi, Faraja Chiwanga, Jennifer Manne-Goehler and 8 more

Abstract read
In one paragraph

Article in Diabetes care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Felix TeufelHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA.ORCID 0000-0002-5293-4783
Katherine OrgutsovaInstitute of Occupational, Social and Environmental Medicine, Centre for Health and Society, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Irini GenitsaridiInternational Diabetes Federation, Brussels, Belgium.
Rodrigo M Carrillo-LarcoHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA.
Jithin Sam VargheseHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA.
Maja E MarcusDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.
Julian W SacreBaker Heart and Diabetes Institute, Melbourne, Australia.
Seyedeh Forough SajjadiBaker Heart and Diabetes Institute, Melbourne, Australia.
Faraja ChiwangaResearch and Consultancy Unit, Muhimbili National Hospital, Dar es Salaam, United Republic of Tanzania.
Jennifer Manne-GoehlerDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.
Jacqueline SeiglieHarvard Medical School, Boston, MA.
David FloodDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI.
Jessica HardingEmory Global Diabetes Research Center, Woodruff Health Sciences Center and Emory University, Atlanta, GA.
Paraskevi SalpeaInternational Diabetes Federation, Brussels, Belgium.
Agus SalimBaker Heart and Diabetes Institute, Melbourne, Australia.
Edward J BoykoDepartment of Medicine, University of Washington, Seattle, WA.
Dianna J MaglianoBaker Heart and Diabetes Institute, Melbourne, Australia.
Mohammed K AliHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA.

Funding

MSDNovo NordiskSanofi
6 · The paper itself

Abstract

objectiveUndiagnosed diabetes leads to delayed treatment and increased risk of complications, exacerbating global disease burdens. In this study, we estimated the prevalence and absolute numbers of individuals with undiagnosed diabetes globally and across regions and quantified gaps in national diabetes detection efforts. RESEARCH DESIGN AND

methodsWe systematically compiled estimates of biomarker-based diabetes prevalence and self-reported diabetes diagnosis using 2003-2024 data from all eligible population-based studies and gray literature. We calculated proportions of individuals with undiagnosed diabetes and case numbers among adults aged 20-79 years. For countries without data, we extrapolated estimates using available data within the same geographic region and country income group. Country-level estimates were benchmarked against the World Health Organization 80% diagnosis target.

resultsWe identified 193 data sources on undiagnosed diabetes from 109 countries. Across all 215 countries/territories, 42.8% of individuals with diabetes were undiagnosed in 2024, equating to 251.7 million (95% uncertainty interval [UI] 250.4-253.0 million) adults. Proportions undiagnosed ranged from 16.2% in Colombia to 90.4% in Burkina Faso and 29.1% in North America and the Caribbean to 72.6% in Africa. A larger proportion of individuals were undiagnosed in low-income (58.7%) compared with high-income countries (28.9%). Middle-income countries accounted for 206.0 million (95% UI 202.3-209.7 million) adults with undiagnosed diabetes (81.8% of all individuals), including 127.1 million (95% UI 121.2-133.0 million [or 50.5%]) adults in China, India, and Indonesia alone. Less than 5% of all countries attained diabetes diagnosis levels ≥80%.

conclusionsSubstantial global variability in undiagnosed diabetes indicates opportunities to close existing care gaps, likely requiring context-specific solutions and investments.

Indexed as

Diabetes MellitusUndiagnosed DiseasesAdultAgedFemaleGlobal HealthHumansMaleMiddle AgedPrevalenceYoung Adult

Identifiers

PMID41604596
PMCPMC13584175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.